Insulin Aspart Crystal
NDC Package 0420-9010-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Insulin Aspart crystals is insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. This formulation utilizes a crystal delivery system. Marketed by Novo Nordisk A/s, this product is identified by NDC 0420-9010.

Identification & Billing

NDC Package Code
0420-9010-01
Package Description
4000 g in 1 CONTAINER
Product Code
0420-9010
11-Digit Billing Format
00420901001

Clinical Specifications

Proprietary Name
Insulin Aspart
Non-Proprietary Name
Insulin Aspart
Substance Name
Insulin Aspart
Dosage Form
Crystal - A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.
Active Ingredient(s)
INSULIN ASPART 1 g/g
Usage Information
Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Regulatory & Marketing

Labeler Name
Novo Nordisk A/s
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
03-25-2010
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0420-9010-01 identifies a specific commercial package of 4000 g in 1 container of Insulin Aspart (UNFINISHED drug), a bulk ingredient labeled by Novo Nordisk A/s. This crystal is formulated for use and contains insulin aspart as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Novo Nordisk A/s on March 25, 2010. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

How is this Novo Nordisk A/s product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00420901001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0420-9010-01
11-Digit CMS (5-4-2)
00420-9010-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.